Position in ZTS
as of Mar 31, 2026
· filed May 11, 2026
Position Value
$226,017
+$11,073 QoQ
Shares Held
1,912
+30.2% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2024
4 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in ZTS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Claret Asset Management Corp holds $23,258,930 across 6 Drug Manufacturers - Specialty & Generic names. ZTS ranks #6 (1.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INDV |
Indivior Pharmaceuticals, Inc.
|
707,267 | $21,557,498 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
806 | $477,941 | |
| 3 | ELAN |
Elanco Animal Health Inc
|
16,017 | $383,286 | |
| 4 | VTRS |
Viatris Inc
|
26,710 | $360,852 | |
| 5 | NBIX |
Neurocrine Biosciences Inc
|
1,923 | $253,336 | |
| 6 | ZTS |
Zoetis Inc.
This page
|
1,912 | $226,017 |
All Filings in ZTS
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $226,017 | 1,912 | Shares | Sole | 2026-05-11 | |
| 2025-09-30 | $214,944 | 1,469 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $232,365 | 1,490 | Shares | Sole | 2025-08-13 | |
| 2024-09-30 | $230,157 | 1,178 | Shares | Sole | 2024-11-14 | |
| No filing history on record for this holder in this stock. | ||||||